pirA (PA0931, Q9I527) notes

Review session 2026-11-05 (PseudoCAP IBA-seed protocol, tier 2)

Fetched with just fetch-gene PSEAE Q9I527 --alias pirA (accession fetch). Accession Q9I527
(Swiss-Prot) matches the worklist. No deep-research keys; literature from cached seed/other
papers (PMID:15899402, PMID:28137795, PMID:33350053, all abstract-only) and the UniProt
record.

Identity

Literature

Annotation decisions

PseudoCAP IBA-seed assessment

PTN node node term n_seeds leaf IBAs seed annotation (term, evidence, PMID) verdict rationale other seeds IBD stands without this seed?
PTN004738955 GO:0015344 siderophore uptake transmembrane transporter activity 4 142 (21 taxa) GO:0015344, IMP, PMID:15899402 SOUND pfeA pirA double mutant, not either single mutant, fails to use ferric enterobactin and catecholate analogues; PirA confirmed as a second ferric-enterobactin receptor. Later: catecholamine-iron uptake, crystal structure. PfeA (Q05098), ChtA (PA4675, Q9HVC0), FvbA (PA4156, Q9HWM5) — PseudoCAP IMP; E. coli CirA (P17315) at the partner process IBD Yes

The node-level assessment of PTN004738955 is recorded once in PA4675-notes.md (IBD sound,
node term suits the clade, no GO_CENTRAL defect). pirA is consistent with it.